A detailed history of Brr Op Co, LLC transactions in Amgen Inc stock. As of the latest transaction made, Brr Op Co, LLC holds 2,082 shares of AMGN stock, worth $656,954. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,082
Previous 2,082 -0.0%
Holding current value
$656,954
Previous $507,000 7.5%
% of portfolio
0.06%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

BUY
$230.71 - $256.74 $10,843 - $12,066
47 Added 2.31%
2,082 $507,000
Q4 2021

Feb 07, 2022

SELL
$198.88 - $227.6 $596,640 - $682,800
-3,000 Reduced 59.58%
2,035 $458,000
Q2 2021

Aug 09, 2021

BUY
$233.58 - $259.14 $15,182 - $16,844
65 Added 1.31%
5,035 $1.23 Million
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $665,730 - $775,800
3,000 Added 152.28%
4,970 $1.24 Million
Q4 2020

Feb 10, 2021

SELL
$216.38 - $257.67 $649,140 - $773,010
-3,000 Reduced 60.36%
1,970 $453,000
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $54,672 - $72,510
-300 Reduced 5.69%
4,970 $1.01 Million
Q4 2019

Jan 31, 2020

SELL
$189.21 - $243.2 $21,569 - $27,724
-114 Reduced 2.12%
5,270 $1.27 Million
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $64,246 - $76,980
-369 Reduced 6.41%
5,384 $1.04 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $60,512 - $70,933
363 Added 6.73%
5,753 $1.06 Million
Q1 2019

Apr 26, 2019

BUY
$180.87 - $203.88 $538,811 - $607,358
2,979 Added 123.56%
5,390 $1.02 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $5,352 - $6,247
-30 Reduced 1.23%
2,411 $469,000
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $2,038 - $2,297
-11 Reduced 0.45%
2,441 $506,000
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $7,472 - $8,392
45 Added 1.87%
2,452 $453,000
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $168 - $188
1 Added 0.04%
2,407 $419,000
Q3 2017

Nov 09, 2017

SELL
$167.29 - $191.0 $16,729 - $19,100
-100 Reduced 3.99%
2,406 $448,000
Q2 2017

Aug 09, 2017

BUY
N/A
2,506
2,506 $432,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Brr Op Co, LLC Portfolio

Follow Brr Op Co, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brr Op Co, LLC with notifications on news.